| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/22/2006 | WO2006065703A1 Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as raf kinase inhibitors |
| 06/22/2006 | WO2006064861A1 Function inhibitor of adam10 or adam17 protein and method of screening the same |
| 06/22/2006 | WO2006064757A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 06/22/2006 | WO2006064286A1 Cathepsin s inhibitors |
| 06/22/2006 | WO2006064121A2 Cytotoxic antibody directed against type b lymphoid hematopoietic proliferations |
| 06/22/2006 | WO2006064072A1 Peptides, nucleotide sequences and cnalinker13 cells and applications thereof |
| 06/22/2006 | WO2006063518A1 Multifunctional polypeptides |
| 06/22/2006 | WO2006063415A1 Regulation of metalloprotease cleavage of cell surface proteins |
| 06/22/2006 | WO2006030437A3 Novel tellurium compounds and their use as immunomodulators |
| 06/22/2006 | WO2004052276A3 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 06/22/2006 | US20060136136 Crystal structure of baff, and use thereof in drug design |
| 06/22/2006 | US20060135776 4-Cyanopyrazole-3-carboxamide derivatives, preparation, and application thereof |
| 06/22/2006 | US20060135622 Amino alcohol derivative, addition salt thereof, and immunosuppressant |
| 06/22/2006 | US20060135620 Novel compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection |
| 06/22/2006 | US20060135613 Carboxamides derivatives |
| 06/22/2006 | US20060135580 One step reaction of compound such as 3,5-dimethyl-isoxazole with butlyllithium and (3,5-di-tert-butyl)-4-hydroxybenzaldehyde, recrystallization/dehydration alcohol in the presence of a base to give (E)-5-[2-(3,5-di-tert-butyl-4-hydroxyphenyl)vinyl]-3-methylisoxazole |
| 06/22/2006 | US20060135575 2-Acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof |
| 06/22/2006 | US20060135573 Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
| 06/22/2006 | US20060135555 Ring fused pyrazole derivatives as CRF antagonists |
| 06/22/2006 | US20060135543 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 06/22/2006 | US20060135539 Thienopyridazinones and their use in modulation of autoimmune disease |
| 06/22/2006 | US20060135534 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 06/22/2006 | US20060135523 2-substituted 5,6-diaryl-pyrazine derivatives as cb1 modulator |
| 06/22/2006 | US20060135519 5-aryltetrazole compounds and compositions thereof |
| 06/22/2006 | US20060135508 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 06/22/2006 | US20060135502 Cyclic derivatives as modulators of chemokine receptor activity |
| 06/22/2006 | US20060135463 Methods and compositions for the treatment of lupus using clofarabine |
| 06/22/2006 | US20060135454 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 06/22/2006 | US20060135431 Peptides and related molecules that bind to TALL-1 |
| 06/22/2006 | US20060135415 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/22/2006 | US20060134706 Atopic dermatitis inducer |
| 06/22/2006 | US20060134203 a water insoluble drug (a cyclosporin or macrolides), a solubilizer, and a surfactant; improved stability, and bioavailability; immunosuppressants |
| 06/22/2006 | US20060134178 Composition containing organic substance having double bond with improved oxidative stability |
| 06/22/2006 | US20060134144 Mucoadhesive composition and formulation for solubilization of insoluble drugs and preparation method thereof |
| 06/22/2006 | US20060134128 Screening for an inhibitor of binding between human Toll-like receptor 3 and a protein of specific amino acid sequence by contacting a candidate with a transfected cell encoding the protein which expresses the receptor; increased interferon in vivo; antitumor, autoimmune agents; side effect reduction |
| 06/22/2006 | US20060134127 Antiallergic agent |
| 06/22/2006 | US20060134126 Peptide constructs for treating disease |
| 06/22/2006 | US20060134124 Immunosuppression |
| 06/22/2006 | US20060134119 Drugs containing galectin 9 |
| 06/22/2006 | US20060134113 Preventive or therapeutic agent for sensitized T cell-mediated diseases comprising IL-6 antagonist as an active ingredient |
| 06/22/2006 | CA2591659A1 Regulation of metalloprotease cleavage of cell surface proteins |
| 06/22/2006 | CA2591413A1 Pyrid-2-ones useful as inhibitors of tec family protein kinases for the treatment of inflammatory, proliferative and immunologically-mediated diseases |
| 06/22/2006 | CA2591399A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 06/22/2006 | CA2590675A1 Nanoparticulate tacrolimus formulations |
| 06/22/2006 | CA2590303A1 Cytotoxic antibody directed against type b lymphoid hematopoietic proliferations |
| 06/22/2006 | CA2590294A1 Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as raf kinase inhibitors |
| 06/22/2006 | CA2587932A1 Antiangiogenesis therapy of autoimmune disease in patients who have failed prior therapy |
| 06/22/2006 | CA2587589A1 Engineered antibodies and immunoconjugates |
| 06/22/2006 | CA2587209A1 Osteoprotegerin variant proteins |
| 06/21/2006 | EP1672368A1 Diagnostic and therapeutic epitope and transgenic plant |
| 06/21/2006 | EP1672065A1 Protein expressed in nk cell |
| 06/21/2006 | EP1671972A1 Octahydropyrrolo[3,4-c]pyrrole derivatives |
| 06/21/2006 | EP1671965A2 Oxacarbocyclic oligomers of fumaric acid |
| 06/21/2006 | EP1671654A2 Conjugates of hydroxyalkyl starch and an active agent |
| 06/21/2006 | EP1671648A1 Prevention and treatment for gvhd |
| 06/21/2006 | EP1671629A1 Human beta-defensin secretion promoter |
| 06/21/2006 | EP1671625A1 Nanoparticles |
| 06/21/2006 | EP1670825A2 Antibodies to m-csf |
| 06/21/2006 | EP1670802A2 Novel heterocyclic compounds as hsp90-inhibitors |
| 06/21/2006 | EP1670510A1 Antibodies against annexins, use thereof for therapy and diagnosis. use of annexins for therapy and diagnosis. |
| 06/21/2006 | EP1670503A1 Immunotherapy method |
| 06/21/2006 | EP1670444A2 Use of indoleacetic acid derivatives which increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various diseases |
| 06/21/2006 | EP1670437A1 Pharmaceutical multiparticulate composition comprising mycophenolic acid or mycophenolate sodium and combination compositions with rapamycin |
| 06/21/2006 | EP1539160B1 Piperidin-2,6-dione pamoate salts and their use for the treatment of stress-related affective disorders |
| 06/21/2006 | EP1463797A4 Methods of kidney transplantation utilizing developing nephric tissue |
| 06/21/2006 | EP1450797B1 Benzothiazole derivatives |
| 06/21/2006 | EP1443915B1 Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes |
| 06/21/2006 | EP1438316B1 Phosphonic acid compounds as inhibitors of serine proteases |
| 06/21/2006 | EP1366049B1 Pirazino¬1'2':1,6|pyrido¬3,4-b|indole derivatives |
| 06/21/2006 | EP1345624B1 Induction of tolerance |
| 06/21/2006 | EP1305047B1 Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplant rejection |
| 06/21/2006 | EP1305041B1 Medicament for the immunotherapy of malignant tumours |
| 06/21/2006 | EP1282599B1 Disulfide derivatives useful for treating allergic diseases |
| 06/21/2006 | EP1268419B1 Pyrrolidine derivatives useful as bax inhibitors |
| 06/21/2006 | EP1222179B1 Process for preparing piperazine-substituted aliphatic carboxylates |
| 06/21/2006 | EP1208092B1 Sulfonamide derivative as a matrix metalloproteinase inhibitor |
| 06/21/2006 | EP1189931B1 Peptide compounds that bind her2 |
| 06/21/2006 | EP1171583B1 A multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides |
| 06/21/2006 | EP1140170B1 Antibody fragments for the topical treatment of ocular diseases |
| 06/21/2006 | EP1128835B1 Cyanocobalamin (vitamin b 12) treatment in allergic disease |
| 06/21/2006 | EP0932626B1 G protein-coupled receptor antagonists |
| 06/21/2006 | EP0912198B1 Immunoliposomes that optimize internalization into target cells |
| 06/21/2006 | CN1791575A Cyanofluoropyrrolidine derivative. |
| 06/21/2006 | CN1791394A Preventive and/or therapeutic agent for inflammatory bowel disease |
| 06/21/2006 | CN1789282A Multifunctional polypeptide |
| 06/21/2006 | CN1788775A Chinese traditional medicine composition for promoting immunity and preparation and quality controlling method thereof |
| 06/21/2006 | CN1788751A A group of injection composition containing glossy privet fruit and astragalus root for strengthening the body resistance |
| 06/21/2006 | CN1788744A Ciliate desert-grass effective parts formulation resin processing method |
| 06/21/2006 | CN1788743A Ciliate desert-grass formulation preparation process and anti-allergic uses |
| 06/21/2006 | CN1788742A Ciliate desert-grass effective parts and allergy-resistant use of effective ingredient |
| 06/21/2006 | CN1260357C Improved anti-IgE antibodies and method of improving polypeptides |
| 06/21/2006 | CN1260227C 5-membered ring heterocyclic compounds with nitrogen |
| 06/21/2006 | CN1260225C Tetrahydropyridino or piperidino hetlrocyclic derivatives |
| 06/21/2006 | CN1260222C Antagonists of mcp-1 function and methods of use thereof |
| 06/21/2006 | CN1259926C Medicine for preventing allergy of dentin |
| 06/21/2006 | CN1259907C Pseudoephedrine hydrochloride dripping pill |
| 06/21/2006 | CN1259845C Donkey-hide gelatin candied date brown sugar and its producing method |
| 06/20/2006 | US7064229 Succinic acid derivatives |
| 06/20/2006 | US7064217 2-Aminoacetamide derivatives with hydroxy-, phosphonate-, and/or methylene phosphonate substituent; antitumor, anticoagulant, antiproliferative, and wound healing agents |
| 06/20/2006 | US7064215 Nitrogen compounds such as 3-(5-morpholin-4-yl-1H-benz-imidazol-2-yl)-1H-indazole and/or isomers, used as immunology modulators, antidiabetic agents, antiogenesis inhibitors or for prophylaxis of Alzheimer's disease |